{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:05:48Z","timestamp":1789790748841,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.berh.2019.101433","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T07:49:38Z","timestamp":1570175378000},"page":"101433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Myalgia in myositis and myopathies"],"prefix":"10.1016","volume":"33","author":[{"given":"Stefanie","family":"Glaubitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Zsch\u00fcntzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2019.101433_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbi.2019.02.030","article-title":"Immune-inflammatory pathways and clinical changes in fibromyalgia patients treated with Mindfulness-Based Stress Reduction (MBSR): a randomized, controlled clinical trial","volume":"80","author":"Andres-Rodriguez","year":"2019","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.berh.2019.101433_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.semarthrit.2016.07.014","article-title":"Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies","volume":"46","author":"Anh-Tu Hoa","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101433_bib3","first-page":"426130","article-title":"Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment","volume":"2012","author":"Bellato","year":"2012","journal-title":"Pain Res Treat"},{"issue":"1","key":"10.1016\/j.berh.2019.101433_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40199-019-00257-4","article-title":"Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial","volume":"27","author":"Bidari","year":"2019","journal-title":"Daru"},{"issue":"5","key":"10.1016\/j.berh.2019.101433_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird","year":"1979","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2019.101433_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000093866","article-title":"Needle electromyographic findings in 98 patients with myositis","volume":"55","author":"Blijham","year":"2006","journal-title":"Eur Neurol"},{"issue":"Pt 6","key":"10.1016\/j.berh.2019.101433_bib7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/brain\/109.6.1087","article-title":"The second wind phenomenon in McArdle's disease","volume":"109","author":"Braakhekke","year":"1986","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.berh.2019.101433_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.berh.2019.101433_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0960-8966(98)00088-1","article-title":"Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports","volume":"8","author":"Bushby","year":"1998","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.berh.2019.101433_bib10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/rheumatology\/kem211","article-title":"The predictive value of creatine kinase, EMG and MRI in diagnosing muscle disease","volume":"46","author":"Cardy","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.berh.2019.101433_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0377-1237(17)30138-7","article-title":"Trichinosis","volume":"56","author":"Chatterjee","year":"2000","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.berh.2019.101433_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fgene.2018.00114","article-title":"Combined therapies for Duchenne muscular dystrophy to optimize treatment efficacy","volume":"9","author":"Cordova","year":"2018","journal-title":"Front Genet"},{"issue":"8","key":"10.1016\/j.berh.2019.101433_bib13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jnnp.2008.168294","article-title":"Toxic and drug-induced myopathies","volume":"80","author":"Dalakas","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"19","key":"10.1016\/j.berh.2019.101433_bib14","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","article-title":"Intravenous immunoglobulin in autoimmune neuromuscular diseases","volume":"291","author":"Dalakas","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.berh.2019.101433_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2009.04.003","article-title":"Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis","volume":"9","author":"Danieli","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.berh.2019.101433_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1212\/01.wnl.0000252252.29532.cc","article-title":"The role of muscle biopsy in investigating isolated muscle pain","volume":"68","author":"Filosto","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.berh.2019.101433_bib17","first-page":"CD003643","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Gordon","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.berh.2019.101433_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/EBC20170114","article-title":"Emerging therapies for mitochondrial diseases","volume":"62","author":"Hirano","year":"2018","journal-title":"Essays Biochem"},{"issue":"4664","key":"10.1016\/j.berh.2019.101433_bib19","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/bmj.1.4664.1230","article-title":"Bornholm disease","volume":"1","author":"Hopkins","year":"1950","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.berh.2019.101433_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.apmr.2007.08.153","article-title":"Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy","volume":"89","author":"Jensen","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"issue":"24","key":"10.1016\/j.berh.2019.101433_bib21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.21037\/atm.2018.10.59","article-title":"Glycogen metabolism and glycogen storage disorders","volume":"6","author":"Kanungo","year":"2018","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.berh.2019.101433_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/cc11304","article-title":"Clinical review: serious adverse events associated with the use of rituximab - a critical care perspective","volume":"16","author":"Kasi","year":"2012","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.berh.2019.101433_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010082","article-title":"Muscle carnitine palmitoyltransferase II deficiency: a review of enzymatic controversy and clinical features","volume":"18","author":"Lehmann","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.berh.2019.101433_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnagi.2014.00177","article-title":"Pompe disease: from pathophysiology to therapy and back again","volume":"6","author":"Lim","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1016\/j.berh.2019.101433_bib25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s13311-018-00679-z","article-title":"Myotonic dystrophies: targeting therapies for multisystem disease","volume":"15","author":"LoRusso","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"11","key":"10.1016\/j.berh.2019.101433_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11926-015-0544-x","article-title":"Role of MRI in diagnosis and management of idiopathic inflammatory myopathies","volume":"17","author":"Maurer","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2019.101433_bib27","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1148\/radiographics.20.suppl_1.g00oc18s295","article-title":"Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls","volume":"20","author":"May","year":"2000","journal-title":"RadioGraphics"},{"key":"10.1016\/j.berh.2019.101433_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/pm\/pnz077","article-title":"Fibromyalgia: an urgent need for harmonized, global, and patient-centric regulatory guidance for developing medications for the treatment of pain and associated symptoms","author":"Merante","year":"2019","journal-title":"Pain Med"},{"issue":"3","key":"10.1016\/j.berh.2019.101433_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/practneurol-2015-001353","article-title":"What's in a name? The clinical features of facioscapulohumeral muscular dystrophy","volume":"16","author":"Mul","year":"2016","journal-title":"Pract Neurol"},{"issue":"2","key":"10.1016\/j.berh.2019.101433_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2019.101433_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11940-017-0473-2","article-title":"Treatment opportunities in patients with metabolic myopathies","volume":"19","author":"Orngreen","year":"2017","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"10.1016\/j.berh.2019.101433_bib32","first-page":"CD004426","article-title":"Treatment for mitochondrial disorders","author":"Pfeffer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.berh.2019.101433_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mus.21015","article-title":"Muscle ultrasound in neuromuscular disorders","volume":"37","author":"Pillen","year":"2008","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.berh.2019.101433_bib34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/rheumatology\/kel336","article-title":"Mycophenolate mofetil treatment in resistant myositis","volume":"46","author":"Pisoni","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.berh.2019.101433_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11926-019-0814-0","article-title":"The role of complementary and alternative medicine treatments in fibromyalgia: a comprehensive review","volume":"21","author":"Prabhakar","year":"2019","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"10.1016\/j.berh.2019.101433_bib36","first-page":"CD003458","article-title":"Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)","author":"Quinlivan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.berh.2019.101433_bib37","first-page":"631","article-title":"Statin therapy: review of safety and potential side effects","volume":"32","author":"Ramkumar","year":"2016","journal-title":"Acta Cardiol Sin"},{"issue":"8","key":"10.1016\/j.berh.2019.101433_bib38","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/01.wnl.0000208416.32471.c0","article-title":"Mycophenolate mofetil in dermatomyositis: is it safe?","volume":"66","author":"Rowin","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.berh.2019.101433_bib39","first-page":"109","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J\u00a0Neuromuscul Dis"},{"issue":"6","key":"10.1016\/j.berh.2019.101433_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/BOR.0000000000000436","article-title":"Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment","volume":"29","author":"Schmidt","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"3B","key":"10.1016\/j.berh.2019.101433_bib41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1590\/S0004-282X2000000500001","article-title":"Diagnosis of dermatomyositis and polymyositis: a study of 102 cases","volume":"58","author":"Scola","year":"2000","journal-title":"Arq Neuropsiquiatr"},{"issue":"9","key":"10.1016\/j.berh.2019.101433_bib42","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1590\/0004-282X20160107","article-title":"Pain characterization in Duchenne muscular dystrophy","volume":"74","author":"Silva","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"10.1016\/j.berh.2019.101433_bib43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11154-016-9357-0","article-title":"Hypothyroid myopathy: a peculiar clinical presentation of thyroid failure. Review of the literature","volume":"17","author":"Sindoni","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.berh.2019.101433_bib44","series-title":"Glycogen storage disease. StatPearls treasure island (FL)","author":"Stone","year":"2019"},{"issue":"17","key":"10.1016\/j.berh.2019.101433_bib45","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-european atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.berh.2019.101433_bib46","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s13311-018-00684-2","article-title":"Myopathies related to glycogen metabolism disorders","volume":"15","author":"Tarnopolsky","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.berh.2019.101433_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5414\/NPP28136","article-title":"Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases","volume":"28","author":"Teijeira","year":"2009","journal-title":"Clin Neuropathol"},{"issue":"3","key":"10.1016\/j.berh.2019.101433_bib48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.berh.2019.101433_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.24307","article-title":"Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy","volume":"51","author":"Van De Vlekkert","year":"2015","journal-title":"Muscle Nerve"},{"issue":"suppl 10","key":"10.1016\/j.berh.2019.101433_bib50","article-title":"2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria [abstract]","volume":"68","author":"Wolfe","year":"2016","journal-title":"Arthritis Rheum"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219301093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219301093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:18:48Z","timestamp":1761499128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694219301093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1521694219301093"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2019.101433","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myalgia in myositis and myopathies","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2019.101433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101433"}}